Search

21/03/2024 Cost-effectiveness of active tuberculosis screening among high-risk populations in low tuberculosis incidence countries: a systematic review, 2008 to 2023
Gogichadze, N, Sagrera, A, Vicente, JA, Millet, JP, López-Segui, F, Vilaplana, C. Cost-effectiveness of active tuberculosis screening among high-risk populations in low tuberculosis incidence countries: a systematic review, 2008 to 2023. Eurosurveillance. 2024; 29(12)DOI:10.2807/1560-7917.ES.2024.29.12.2300614. PMID:38516785. IF:7.800(Q1/1D).
01/10/2022 Quality of hospital emergency department care for patients with COVID-19 during the first wave in 2020: the CALUR-COVID-19 study
Jimenez, S, Miro, O, Alquezar-Arbe, A, Pinera, P, Jacob, J, Llorenss, P, Garcia-Lamberechts, EJ, Martin-Sanchez, FJ, Del Castillo, JG, Burillo-Putze, G. Quality of hospital emergency department care for patients with COVID-19 during the first wave in 2020: the CALUR-COVID-19 study. EMERGENCIAS. 2022; 34(5)DOI:. PMID:36217932. IF:5.500(Q1/2D).
01/12/2023 Use of digoxin in the emergency department to treat patients with acute heart failure and its impact on short-term outcomes
Mojarro, EM, Gil, V, Llorens, P, Alvarez, J, Quesada, SF, Ungerer, OJT, Alquezar-Arbé, A, Jacob, J, Herrero-Puente, P, Espinosa, B, Sánchez, C, Llauger, L, Tost, J, Serrano, L, Dávila, A, Garate, RT, López-Grima, ML, Lucas-Imbernón, FJ, Alonso, H, Pagán, F, Garrido, JM, Miró, O. Use of digoxin in the emergency department to treat patients with acute heart failure and its impact on short-term outcomes. EMERGENCIAS. 2023; 35(6)DOI:. PMID:38116968. IF:5.400(Q1/1D).
01/01/2022 Factores asociados con mortalidad a corto plazo en personas que viven en residencias atendidas en servicios de urgencias: resultados del estudio multicéntrico Caregency
Afonso-Argilés F.J., Comas Serrano M., Blázquez-Andión M., Castells Oliveres X., Cirera Lorenzo I., García Pérez D., Gómez Roldán J.M., Pujadas Lafarga T., Ichart Tomás X., Puig-Campmany M., Rizzi M.A., Sinfreu Pujol A., Tejero Cano I., Vena Martínez A.B., Villanueva Sánchez H., Renom-Guiteras A.. Factores asociados con mortalidad a corto plazo en personas que viven en residencias atendidas en servicios de urgencias: resultados del estudio multicéntrico Caregency. EMERGENCIAS. 2022; 34(6)DOI:. PMID:36625693. IF:5.500(Q1/2D).
01/06/2025 Clinical-epidemiological aspects, hospitalization, and reconsultations in older patients with atrial fibrillation in emergency departments in Spain (EDEN-35 study): sex-disaggregated analysis
Coll-Vinent, B, Hernández, NM, Marco, NC, Boixeda, C, Rodríguez, JJ, Alquézar-Arbé, A, Alonso, CF, Burillo-Putze, G, Montero-Pérez, FJ, del Castillo, JG, Miró, O. Clinical-epidemiological aspects, hospitalization, and reconsultations in older patients with atrial fibrillation in emergency departments in Spain (EDEN-35 study): sex-disaggregated analysis. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/035.2025. PMID:40531120. IF:6.300(Q1/1D).
01/06/2026 Standardizing MRI-only radiotherapy commissioning: Benchmark dataset and acceptance levels from the MESCAL initiative
Cusumano, D, Maspero, M, Vellini, L, Alvarez-Michael, E, Barateau, A, Bessieres, I, Bohoudi, O, Dal Bello, R, Dufreneix, S, Kurz, C, Landry, G, Milan, L, Palacios, MA, Pastore, G, Robert, C, Seravalli, E, Tejedor, N, Trnkova, P, Villegas, F, Vieillevigne, L, Wyatt, J, Yadav, P, Placidi, L, Fusella, M. Standardizing MRI-only radiotherapy commissioning: Benchmark dataset and acceptance levels from the MESCAL initiative. RADIOTHERAPY AND ONCOLOGY. 2026; 219DOI:10.1016/j.radonc.2026.111530. PMID:41980670. IF:5.300(Q1/2D).
01/05/2024 Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios
Hardcastle, N, Osorio, EV, Jackson, A, Mayo, C, Aarberg, AE, Ayadi, M, Belosi, F, Ceylan, C, Davey, A, Dupuis, P, Handley, JC, Hemminger, T, Hoffmann, L, Kelly, C, Michailidou, C, Muscat, S, Murrell, DH, Pérez-Alija, J, Palmer, C, Placidi, L, Popovic, M, Ronde, HS, Selby, A, Skopidou, T, Solomou, N, Stroom, J, Thompson, C, West, NS, Zaila, A, Appelt, AL. Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:10.1016/j.radonc.2024.110184. PMID:38453055. IF:5.300(Q1/2D).
01/04/2026 ESTRO's principles for environmental sustainability in the radiation oncology community
Tanderup, K, Kirby, AM, Eriksen, JG, Jornet, N, Bertholet, J, Gasparotto, C, Aznar, MC, Boldrini, L, Borgmann, K, Clark, CH, Forde, E, Jereczek-Fossa, BA, Heide, UAV, Hurkmans, C, Meattini, I, Ost, P, Troost, EGC, Cortese, A, Guckenberger, M. ESTRO's principles for environmental sustainability in the radiation oncology community. RADIOTHERAPY AND ONCOLOGY. 2026; 217DOI:10.1016/j.radonc.2026.111384. PMID:41621681. IF:5.300(Q1/2D).
02/03/2026 From data to treatment plan: An AI-driven path for automated breast radiotherapy planning
Gallego, P, Ambroa, E, Pérez-Alija, J, Julià, JC, Jornet, N, Matas, A, Anson, C, Mera, A, Tejedor, N, Vivancos, H, Ruiz, A, Barceló, M, Dominguez, A, Riu, V, Roda, J, Carrasco, P, Balocco, S, Díaz, O. From data to treatment plan: An AI-driven path for automated breast radiotherapy planning. Journal of Applied Clinical Medical Physics. 2026; 27(3)DOI:10.1002/acm2.70491. PMID:41769854. IF:2.200(Q2/5D).
01/03/2026 Guide for quality control and safety in clinical linear accelerators?
Manzano, PA, Rey, EA, Gracia, CF, Albaladejo, MM, Fernández, JPA, Oliver, RT, Pacheco, MV, Valverde, FL. Guide for quality control and safety in clinical linear accelerators?. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2026; 143DOI:10.1016/j.ejmp.2026.105747. PMID:41679132. IF:2.700(Q2/4D).
01/01/2025 Anatomical and functional results of plasma rich in growth factors as a treatment for poor-prognosis macular holes.
Caminal-Caramés M, Vilimelis JC, Quinto CO, Pernias AS, Conversa S, Reyes AV, Cascajosa JD, Lorca DR, Pérez MPP, Segarra JIV. Anatomical and functional results of plasma rich in growth factors as a treatment for poor-prognosis macular holes.. Romanian Journal Of Ophthalmology. 2025; 69(4)DOI:10.22336/rjo.2025.81. PMID:41971203. IF:(Q/D).
01/05/2024 Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022)
Fernández, CPH, Borrego, L, Arnau, AMG, Ninet, VZ, Sánchez, TS, Miquel, FJM, Pérez, RG, Salvador, JFS, Guijarro, SC, Carrillo, JMC, Ortega, MEG, González, IR, García, PM, Romero, FT, Baldrich, ES, Pastor-Nieto, MA, Serna, MR, Pérez, JS, Gilo, AS, Ninot, GM, Guillén, PSP, Martínez, MD, Descalzo, MAG, Doval, IG. Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022). CONTACT DERMATITIS. 2024; 90(5)DOI:10.1111/cod.14513. PMID:. IF:4.600(Q1/1D).
01/03/2026 Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors
Blauvelt, A, Strober, BE, Eakin, GS, Howard, LM, Langan, C, van de Kerkhof, PCM, Puig, L, Lebwohl, MG, Romiti, R, Armstrong, AW, Choon, SE, Ramessur, R, Gelfand, JM, Merola, JF, Winthrop, KL, Torres, T. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; 94(3)DOI:10.1016/j.jaad.2025.11.033. PMID:41260526. IF:11.800(Q1/1D).
01/04/2026 Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis: A Multicenter Case-Control Study
Garbayo-Salmons, P, Molina-Leyva, A, Porta-Vilaró, A, Soto-Moreno, A, Fornons-Servent, R, Gamissans, M, Garcias-Ladaria, J, Gracia-Darder, I, Martin-Ezquerra, G, Verdaguer-Faja, J, Mora-Fernández, V, Aguayo-Ortiz, RS, Vilarrasa, E, Masferrer, E, Corral-Magaña, O, Galvany, L, Rodrigo-Parés, A, Saus, E, Moreno, M, Carreras, A, Feliu-Hernàndez, C, Exposito-Serrano, V, Ribera, M, Sabat, M, Calvet, J. Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis: A Multicenter Case-Control Study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(4)DOI:10.1111/ijd.70125. PMID:41164894. IF:3.200(Q1/3D).
01/02/2026 Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study
Krüger-Szabo, A, Ameen, A, Serra-Baldrich, E, Armstrong, AW, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2026; 24DOI:. PMID:. IF:3.800(Q1/2D).
02/03/2026 Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis
Queiro-Silva, R, López-Ferrer, A, Farrés, MFI, Rivera-Díaz, R, Vidal-Sarro, D, Fernández-Freire, LR, de la Cueva-Dobao, P, Santos-Juanes, J, Rocamora-Duran, V, Gómez-Labrador, L, Belinchón-Romero, I. Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis. PLoS One. 2026; 21(3)DOI:10.1371/journal.pone.0342498. PMID:41770732. IF:2.600(Q2/4D).
01/04/2026 Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC
Sánchez, TS, Giménez-Arnau, AM, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, Pérez, RG, González, IR, Mercader-García, P, Baldrich, ES, Carrillo, JMC, Romero, FT, De Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Navarro-Triviño, F, Chicharro, P, Nieto, MAP, de la Fuente, EG, Sánchez-Gilo, A, Andreu-Barasoain, M, Rodríguez, JJP, Ninot, GMI, Guillén, PS, Elosua-González, M, Grau-Pérez, M, Descalzo, MA, Borrego, L. Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC. CONTACT DERMATITIS. 2026; 94(4)DOI:10.1111/cod.70082. PMID:41456936. IF:4.600(Q1/1D).
01/04/2026 Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis The BE RADIANT Randomized Clinical Trial With Open-Label Extension
Augustin, M, Feldman, SR, Warren, RB, Armstrong, A, Vender, R, López-Ferrer, A, Dawe, WH, Lambert, J, Szilagyi, B, Hoepken, B, Warham, R, Gottlieb, AB. Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis The BE RADIANT Randomized Clinical Trial With Open-Label Extension. JAMA Dermatology. 2026; 162(4)DOI:10.1001/jamadermatol.2025.6055. PMID:41706476. IF:11.000(Q1/1D).
01/04/2026 Risk factors for close or involved margins in cutaneous squamous cell carcinoma of the scalp
Verdaguer-Faja, J, Ferrándiz-Pulido, C, Podlipnik, S, Guerra-Amor, A, Abril-Pérez, C, Estrada, RB, Masferrer, E, Lopez-Castillo, D, Deza, G, Leal, L, Marti-Marti, I, Ruiz-Salas, V, Yébenes, M, Martin, LM, Baliu, C, Castany, A, Boada, A, Toll, A, Jaka, A. Risk factors for close or involved margins in cutaneous squamous cell carcinoma of the scalp. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2026; 40(4)DOI:10.1111/jdv.20872. PMID:40709565. IF:8.000(Q1/1D).
01/03/2026 Economic Burden of Hidradenitis Suppurativa in Spain
Vilarrasa, E, Borrás-Blasco, J, Lobo-Benito, S, Loro-Pérez, M, Núñez-García, MG, Oliva-Moreno, J, Palacios-Martínez, D, Rubial-Bernárdez, F, Ivanova-Markova, Y, Daheron, M, Bellas, J, Martorell, A. Economic Burden of Hidradenitis Suppurativa in Spain. Dermatology and Therapy. 2026; 16(3)DOI:10.1007/s13555-026-01669-2. PMID:41723775. IF:4.200(Q1/1D).